PROCTER & GAMBLE HEALTH | SANOFI INDIA | PROCTER & GAMBLE HEALTH/ SANOFI INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.5 | 31.0 | 111.1% | View Chart |
P/BV | x | 10.5 | 15.4 | 68.2% | View Chart |
Dividend Yield | % | 2.0 | 7.0 | 28.7% |
PROCTER & GAMBLE HEALTH SANOFI INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SANOFI INDIA Dec-22 |
PROCTER & GAMBLE HEALTH/ SANOFI INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 7,939 | 67.6% | |
Low | Rs | 3,883 | 5,454 | 71.2% | |
Sales per share (Unadj.) | Rs | 740.7 | 1,202.8 | 61.6% | |
Earnings per share (Unadj.) | Rs | 138.2 | 269.5 | 51.3% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 287.7 | 53.9% | |
Dividends per share (Unadj.) | Rs | 95.00 | 570.00 | 16.7% | |
Avg Dividend yield | % | 2.1 | 8.5 | 24.1% | |
Book value per share (Unadj.) | Rs | 447.6 | 527.0 | 84.9% | |
Shares outstanding (eoy) | m | 16.60 | 23.03 | 72.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 5.6 | 112.1% | |
Avg P/E ratio | x | 33.5 | 24.9 | 134.6% | |
P/CF ratio (eoy) | x | 29.8 | 23.3 | 128.0% | |
Price / Book Value ratio | x | 10.3 | 12.7 | 81.3% | |
Dividend payout | % | 68.7 | 211.5 | 32.5% | |
Avg Mkt Cap | Rs m | 76,761 | 154,224 | 49.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 4,059 | 50.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 27,701 | 44.4% | |
Other income | Rs m | 184 | 730 | 25.2% | |
Total revenues | Rs m | 12,480 | 28,431 | 43.9% | |
Gross profit | Rs m | 3,247 | 8,349 | 38.9% | |
Depreciation | Rs m | 281 | 419 | 67.1% | |
Interest | Rs m | 8 | 17 | 45.3% | |
Profit before tax | Rs m | 3,142 | 8,643 | 36.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 2,437 | 34.8% | |
Profit after tax | Rs m | 2,295 | 6,206 | 37.0% | |
Gross profit margin | % | 26.4 | 30.1 | 87.6% | |
Effective tax rate | % | 27.0 | 28.2 | 95.6% | |
Net profit margin | % | 18.7 | 22.4 | 83.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 36,121 | 32.4% | |
Current liabilities | Rs m | 6,791 | 27,425 | 24.8% | |
Net working cap to sales | % | 40.0 | 31.4 | 127.5% | |
Current ratio | x | 1.7 | 1.3 | 131.0% | |
Inventory Days | Days | 263 | 117 | 225.2% | |
Debtors Days | Days | 343 | 17 | 2,019.2% | |
Net fixed assets | Rs m | 10,617 | 12,148 | 87.4% | |
Share capital | Rs m | 166 | 230 | 72.2% | |
"Free" reserves | Rs m | 7,265 | 11,906 | 61.0% | |
Net worth | Rs m | 7,431 | 12,136 | 61.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 48,279 | 46.3% | |
Interest coverage | x | 409.1 | 509.4 | 80.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.6 | 96.0% | |
Return on assets | % | 10.3 | 12.9 | 80.0% | |
Return on equity | % | 30.9 | 51.1 | 60.4% | |
Return on capital | % | 42.4 | 71.4 | 59.4% | |
Exports to sales | % | 0 | 14.1 | 0.0% | |
Imports to sales | % | 13.1 | 14.6 | 89.6% | |
Exports (fob) | Rs m | NA | 3,904 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 4,037 | 39.8% | |
Fx inflow | Rs m | 1,465 | 3,904 | 37.5% | |
Fx outflow | Rs m | 1,605 | 4,037 | 39.8% | |
Net fx | Rs m | -140 | -133 | 105.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 3,987 | 59.2% | |
From Investments | Rs m | -215 | 6,509 | -3.3% | |
From Financial Activity | Rs m | -985 | -15,827 | 6.2% | |
Net Cashflow | Rs m | 1,160 | -5,331 | -21.8% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 51.8 | 60.4 | 85.8% | |
Indian inst/Mut Fund | % | 20.3 | 28.8 | 70.3% | |
FIIs | % | 7.6 | 6.3 | 120.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 39.6 | 121.7% | |
Shareholders | 56,730 | 62,870 | 90.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: SUN PHARMA CIPLA DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Sanofi India | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.55% | 2.06% | 1.18% |
1-Month | -7.47% | -8.09% | -0.75% |
1-Year | -3.02% | 44.45% | 61.82% |
3-Year CAGR | -9.12% | 0.97% | 18.16% |
5-Year CAGR | 5.75% | 7.07% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Sanofi India share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Sanofi India the stake stands at 60.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Sanofi India.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Sanofi India paid Rs 570.0, and its dividend payout ratio stood at 211.5%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Sanofi India.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.